ACADIA Pharmaceuticals Inc
ACAD
NASDAQ
Biotechnology
$28.24
USD
-0.14 (-0.49%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $4.89B
Volume 1.1M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
DNTH | Dianthus Therapeutics Inc | $6.19B | - | -60.8% | - | |
PTCT | PTC Therapeutics Inc | $6.12B | - | -42.8% | - | |
ORKA | Oruka Therapeutics Inc | $5.98B | - | - | - | |
TVTX | Travere Therapeutics Inc | $5.74B | - | +77.1% | - | |
ACAD | ACADIA Pharmaceuticals Inc | $5.03B | 13.23 | +47.0% | - | |
DYN | Dyne Therapeutics, Inc | $4.95B | - | - | - | |
TNGX | Tango Therapeutics Inc | $4.51B | - | +39.0% | - | |
CELC | Celcuity Inc | $4.45B | - | - | - | |
RLAY | Relay Therapeutics Inc | $4.37B | - | +23.9% | - |
Top Peer by Growth
Travere Therapeutics Inc
+77.1% YoY Revenue
Lowest P/E Ratio
ACADIA Pharmaceuticals Inc
12.85x P/E
Best 1-Year Return
Erasca Inc
+1091.0% Return